Name: TransMedics Group, Inc. (TMDX) Financial Statements
Creator: FinSpry

TransMedics Group Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

TransMedics Group, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Revenue & Gross Profit
Revenue	441.54	241.62	93.46	30.26	25.64	23.60
Cost of Revenue	179.46	87.53	28.19	0.07	9.00	9.74
Gross Profit	262.08	154.09	65.27	30.19	16.64	13.86
Operating Expenses
Research & Development	55.97	36.06	26.81	22.30	18.83	19.87
Selling, General & Administrative	168.62	119.55	69.90	38.28	24.19	23.60
Operating Expenses	224.59	182.82	96.71	60.59	43.02	43.47
Operating Income	37.50	-28.73	-31.44	-39.43	-26.38	-29.60
Other Income/Expense
Interest Income	0.00	12.50	0.90	-0.88	0.00	0.00
Interest Expense	14.41	-10.79	3.73	3.87	-3.99	0.00
Other Income/Expense	-1.72	0.35	-1.90	0.88	-1.65	-0.45
Income
Income Before Tax	35.78	-26.67	-36.17	-44.18	-28.72	-33.51
Income Tax Expense	0.32	-1.64	0.07	0.04	0.03	0.04
Net Income	35.46	-25.03	-36.23	-44.22	-28.70	-33.55
Net Income - Continuous Operations	35.46	-25.03	-36.23	-44.22	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	69.95	-18.49	-28.96	-38.49	-23.15	-28.14
EBIT	35.78	-26.67	-32.44	-40.31	-24.73	-29.15
Depreciation & Amortization	19.76	8.18	3.48	1.82	1.58	-1.22
Earnings Per Share
Basic EPS	1.00	-1.00	-1.00	-2.00	-1.00	-
Diluted EPS	1.00	-1.00	-1.00	-2.00	-1.00	-2.00
Basic Shares Outstanding	33.23	32.52	29.56	27.62	24.70	14.20
Diluted Shares Outstanding	35.22	32.52	29.56	27.62	24.70	14.21